California Business Journal

ELEVAI Elevates Skincare Sector With A Science-Backed Approach

ELEVAI Labs Inc. announced an initial public offering to raise USD 6 million to further grow its medical research and relating products in skincare. The company has developed a unique technology for exosomes, which ensures ethical stem cell acquisition and easy storage and use of its products. Dr. Jordan R. Plews, Founder and CEO of ELEVAI Labs Inc., a medical aesthetics company specializing in physician-dispensed skincare, told the California Business Journal about the company’s future plans.

To read the full interview click here.